secwatch.observer — SEC 8-K summary
======================================

Issuer:     MARIMED INC. (MRMD)
CIK:        0001522767
Form:       8-K
Filed at:   2025-03-05T23:59:59+00:00
Accession:  0001522767-25-000010
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MariMed reports record FY2024 revenue $158M; Q4 margins compress, adjusted EBITDA up in Q4
--------------------------------------------------------------------------------

- Q4 2024 revenue $39.0M (vs $38.9M); full-year revenue $158.0M (+6.3% YoY).
- GAAP gross margin fell to 33% in Q4 from 45% YoY; full-year margin 40% vs 44%.
- Full-year GAAP net loss improved to $12.1M from $16.0M; adjusted EBITDA $19.6M vs $24.7M.
- Wholesale revenue up 29% annually; Betty's Eddies top-selling edible in MA and MD.
- CEO cites 10 revenue-generating assets added over past two years for 2025 growth.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1522767/000152276725000010/0001522767-25-000010-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1522767/000152276725000010/mrmd-20250305.htm
  HTML page:      https://secwatch.observer/filing/0001522767-25-000010

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer